FDA approves new treatment for certain digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of GEP-NETs. Lutathera is indicated for adult patients with somatostatin receptor-positive GEP-NETs.

More information

Advertisements

International Conference on Nuclear Medicine and Radiation Therapy

International Conference on Nuclear Medicine and Radiation Therapy

Madrid, Spain July 16-17, 2018

19th European Symposium on Radiopharmacy and Radiopharmaceuticals

19th European Symposium on Radiopharmacy and Radiopharmaceuticals.

April 05-08, 2018 • Groningen, Netherlands

Link

 

New version of Radiolab

A new version of Radiolab -application for comprehensive management of hospital radiopharmacies- is now available at www.radiopharmacy.net. Radiolab 4.0 includes among others the following new features:

• Addition of small, medium and large labels for radioactive products and cold kits.
• Addition of Ga-68 generator in the Generators module.
• Each user can change their own password in the Maintenance module without relying on the Administrator. This new functionality is only active in the registered versions of Radiolab.
• The activity of the radionuclides in the Waste module is now shown in mCi and Bq. Only those radionuclides having at least a residual activity of 0.01 Bq are shown.
• The user who made the last backup of the Radiolab database is registered, and also when and where they made the backup is registered.
• Effective doses are automatically calculated at two different times. Firstly, they are automatically calculated when you import the prescriptions in the Prescriptions section of the Dispensing module. And secondly, each effective dose is automatically recalculated when the administered radiopharmaceutical, its activity or the patient’s age is modified in the Dispensing module.
• The Dosimetry section has been included in the Traceability module, which allows the reporting of the effective doses of all radiopharmaceuticals administered to every patient, as well as the cumulative total effective dose of all of them.

EANM’17

30th Annual Meeting of the European Association of Nuclear Medicine.

October 21 – 25, 2017   Vienna, Austria

More information

Certificate of Advanced Studies in Radiopharmaceutical Chemistry/Radiopharmacy

Postgraduate course to obtain the “Certificate of Advanced Studies in Radiopharmaceutical Chemistry/Radiopharmacy”.

August 28-September 8, 2017. Faculty of Pharmacy, University of Ljubljana, Slovenia More information

SNMMI 2017 Annual Meeting

The Society of Nuclear Medicine & Molecular Imaging (SNMMI) is now accepting abstracts for the SNMMI 2017 Annual Meeting, June 10-14, 2017 in Denver, CO.

Link